These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19081768)

  • 1. Elevated serum macrophage migration inhibitory factor (MIF) concentrations in chronic kidney disease (CKD) are associated with markers of oxidative stress and endothelial activation.
    Bruchfeld A; Carrero JJ; Qureshi AR; Lindholm B; Barany P; Heimburger O; Hu M; Lin X; Stenvinkel P; Miller EJ
    Mol Med; 2009; 15(3-4):70-5. PubMed ID: 19081768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
    Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
    Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis.
    Shang ZB; Wang J; Kuai SG; Zhang YY; Ou QF; Pei H; Huang LH
    Ann Lab Med; 2018 Jan; 38(1):9-16. PubMed ID: 29071813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressions of macrophage migration inhibitory factor in patients with chronic kidney disease.
    Liu Y; Zhang X; Liu G; Huang J; Pan Y; Hu Z
    Niger J Clin Pract; 2016; 19(6):778-783. PubMed ID: 27811451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.
    Bruchfeld A; Wendt M; Miller EJ
    Front Immunol; 2016; 7():8. PubMed ID: 26858715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
    Rammos C; Hendgen-Cotta UB; Sobierajski J; Adamczyk S; Hetzel GR; Kleophas W; Dellanna F; Kelm M; Rassaf T
    Int J Cardiol; 2013 Oct; 168(6):5249-56. PubMed ID: 23978362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Znorko B; Mor AL; Mysliwiec M; Pawlak D
    Int Urol Nephrol; 2019 Mar; 51(3):491-502. PubMed ID: 30617956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD).
    Bruchfeld A; Qureshi AR; Lindholm B; Barany P; Yang L; Stenvinkel P; Tracey KJ
    Mol Med; 2008; 14(3-4):109-15. PubMed ID: 18317568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MIF reflects tissue damage rather than inflammation in post-cardiac arrest syndrome in a real life cohort.
    Pohl J; Rammos C; Totzeck M; Stock P; Kelm M; Rassaf T; Luedike P
    Resuscitation; 2016 Mar; 100():32-7. PubMed ID: 26784134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor.
    Kozaci LD; Sari I; Alacacioglu A; Akar S; Akkoc N
    Mod Rheumatol; 2010 Feb; 20(1):34-9. PubMed ID: 19787418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
    Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated interleukin-12 and interleukin-18 in chronic kidney disease are not associated with arterial stiffness.
    Yong K; Ooi EM; Dogra G; Mannion M; Boudville N; Chan D; Lim EM; Lim WH
    Cytokine; 2013 Oct; 64(1):39-42. PubMed ID: 23778029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
    Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
    PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between PCSK9 Levels and Markers of Inflammation, Oxidative Stress, and Endothelial Dysfunction in a Population of Nondialysis Chronic Kidney Disease Patients.
    Dounousi E; Tellis C; Pavlakou P; Duni A; Liakopoulos V; Mark PB; Papagianni A; Tselepis AD
    Oxid Med Cell Longev; 2021; 2021():6677012. PubMed ID: 34336112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
    Hao Y; Yi SL; Zhong JQ
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):556-60. PubMed ID: 26263432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury.
    Yang DB; Yu WH; Dong XQ; Zhang ZY; Du Q; Zhu Q; Che ZH; Wang H; Shen YF; Jiang L
    Clin Chim Acta; 2017 Jun; 469():99-104. PubMed ID: 28366792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
    Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.
    Müller II; Müller KA; Schönleber H; Karathanos A; Schneider M; Jorbenadze R; Bigalke B; Gawaz M; Geisler T
    PLoS One; 2012; 7(6):e38376. PubMed ID: 22693633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.